ESR1 and breast cancer: Unacylated ghrelin at 100pM caused a significant reduction in the serum-induced growth of ER+ breast cancer cells, while inhibiting or having no effect in the TNBC patient samples examined (Figure 5g, Figure 5—figure supplement 1e; Table 1).